contacts Sign In

image

Neuravi

Be the first one to rate! Submit Review

Neuravi is dedicated to improving clinical outcomes for stroke patients. The company’s stroke therapy platform, the EmboTrap®II Revascularization Device, is CE marked and commercially available in Europe. The device has been available for investigational use only in the United States. Through its investment in the Neuravi Thromboembolic Initiative (NTI), Neuravi supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics, in order to improve patient outcomes in stroke.

In April 2017, Codman Neuro announced the acquisition of Neuravi, which is now part of the Johnson and Johnson family of medical device companies. Neuravi was founded in 2009 and is headquartered in Galway, Ireland.

Company’s Keywords:

Related Companies：

  1. Referencia Laboratorio Clínico
  2. Q5 Healthcare
  3. Primacel Group – High Quality Foam
  4. Ministry of Health and Social Services
  5. Surgiris
  6. Mirabilis Medica, Inc.
  7. Infraredx, a Nipro Company
  8. Candore Bioscience
  9. Ozark Prosthetics & Orthotics
  10. Newton Photonics
Q How Many Employees Does This Company Have?

5

Q Which Industry Does This Company Belong To?

medical devices

Q What Is the Annual Income?

2500000

Q What Is the Technology of All the Company’s Website?

Q What Year Was the Company Founded?

2009

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

Claiming your business Listing

Claim request is processed after verification..

image

image
Doctor
Visit Profile

imageYour request has been submitted successfully.

image